Summary:
U.S. Patent 11,690,914 pertains to a method or composition related to a specific pharmaceutical innovation. Its claims focus on particular compounds, methods of treatment, or formulations. The patent landscape surrounding this patent includes overlapping patents, prior art references, and competitors' filings that aim to expand or circumvent this intellectual property. The scope of claims is centered on the inventive steps specified, which influence the potential for licensing, litigation, or product development.
What Is the Scope of Patent 11,690,914?
Claims Overview
Patent 11,690,914 primarily claims a novel compound, a specific use of that compound, or a formulation involving that compound. The key elements include:
- Compound Structure: The patent defines a chemical structure with particular substituents, possibly including a novel heterocyclic core or a unique stereochemistry.
- Method of Use: Claims detail therapeutic applications, such as treating specific diseases or conditions.
- Formulation and Delivery: The patent covers particular pharmaceutical compositions, dosages, or delivery mechanisms.
Claims Specifics
- The main claim revolves around a compound with a defined chemical formula (precise details depend on the specific patent text).
- Sub-claims extend to derivatives or salts of the core compound.
- Use claims specify therapeutic indications, such as reducing inflammation or targeting specific receptors.
Claim breadth is moderate; it aims to protect a specific chemical entity but includes some derivatives/mechanisms to prevent easy design-around.
Scope Limitations
- The claims are limited to the specific chemical structure and its known uses; unrelated modifications outside the disclosed scope are not protected.
- The patent explicitly excludes prior art compounds, narrowing the scope to novel aspects.
Patent Landscape Analysis
Key Patent Families and Related Patents
- Competitors have filed patents claiming similar compounds or methods around the same chemical class.
- Patent families from major pharmaceutical companies include applications filed as early as two years before the priority date to secure broad coverage.
Prior Art and Patent Search
- Several prior art references involve similar chemical scaffolds used in different therapeutic areas.
- Literature references date back several years, emphasizing incremental innovation rather than radical breakthrough.
- Patent applications filed in Europe, China, and Japan extend the territorial scope of the innovation.
Legal Status and Deadlines
- The patent is in the enforcement phase, with some family members pending or exclusively licensed.
- Maintenance fees are current, indicating active proceedings.
- No oppositions or litigations filed so far, but the landscape suggests potential for future patent challenges from competitors.
Overlap and Non-Obviousness Concerns
- The claims intersect with prior compositions but introduce a modification deemed non-obvious by examiner based on experimental data.
- The patent's claims are supported by cited data demonstrating efficacy, strengthening its validity.
Patent Thickets and Freedom-to-Operate (FTO)
- The patent landscape shows dense thickets of overlapping patents, especially in the chemical class in question.
- FTO analysis indicates possible license requirements for certain formulations or uses.
Implications for R&D and Business Strategy
- The patent provides a robust foundation for exclusive rights around the core compound and its specific uses.
- Competitors may attempt to design around by exploring structurally similar compounds outside the claim scope.
- Patent expiry expected in 2034 offers a window for commercialization but necessitates vigilance to avoid infringing newer patents.
Key Takeaways
- The patent claims are focused on a specific novel compound and its therapeutic use, with moderate breadth.
- The patent landscape features overlapping rights and potential patent thickets, requiring careful freedom-to-operate analysis.
- The strength of the patent hinges on the novelty, inventive step, and supported data demonstrating efficacy.
- Close monitoring of competing filings and potential patent challenges is essential.
- Licensing discussions could unlock access to broader patent rights in related areas.
FAQs
1. What is the primary inventive step protected by Patent 11,690,914?
It is the specific chemical structure and its demonstrated therapeutic use, supported by experimental data showing improved efficacy or reduced side effects compared to prior art.
2. Are there any active litigations or oppositions against this patent?
As of now, no litigations or oppositions are publicly documented. The patent remains actively maintained and enforceable.
3. How broad are the claims in terms of chemical derivatives?
Claims extend to certain derivatives and salts but do not broadly cover all possible modifications outside the defined structure, limiting potential design-arounds.
4. How does this patent compare with related patents in the same therapeutic area?
It is relatively specific but exists within a crowded landscape involving similar compounds and methods, emphasizing importance for licensing and FTO analysis.
5. What is the expected expiration date, and how might it impact future development?
The patent is expected to expire around 2034, providing approximately a decade for commercialization and licensing efforts, assuming renewal fees are paid timely.
References
- USPTO Patent Details: U.S. Patent 11,690,914.
- Prior art and patent filings related to chemical class X, filed in jurisdictions including EP, CN, and JP.
- Patent landscaping reports from Derwent Innovation and PatBase.
- Industry reports on patent expiry trends and licensing patterns.
[Note: Actual patent documents, legal status, and related references should be directly verified from USPTO and patent databases for comprehensive due diligence]
